LifeScience Biologics

Vertex's Breakthrough VX-548: Transforming Pain Management with Rapid Relief and Safety, A New Era in Acute Pain Solutions

Treatment with VX-548 led to statistically significant improvement in pain compared to placebo as well as a clinically meaningful reduction in pain from ...

 January 31, 2024 | News

Fresenius Kabi Launches Posaconazole Injection for Fungal Infection Prevention/Treatment

Fresenius Kabi announced it has introduced Posaconazole Injection, a generic substitute for Noxafil®, for use in treating or preventing serious fungal ...

 January 30, 2024 | News

CellVax Therapeutics Receives FDA Clearance for FK-PC101 Cancer Immunotherapy IND

FK-PC101 is CellVax's novel personalized cancer immunotherapy intended to treat prostate cancer patients who have a high risk of recurrence after prostatec...

 January 30, 2024 | News

Vesicure Therapeutics Advances Exosome-Based KRAS Mutation Targeting

This technology has emerged as a great strategy for treating a range of diseases, including cancer, viral infections, and genetic disorders. In the US, fiv...

 January 30, 2024 | News

Oricell's OriCAR-017 CAR-T Therapy IND Cleared by FDA for Relapsed/Refractory Multiple Myeloma

OriCAR-017 is a chimeric antigen receptor (CAR) T cell therapy targeting GPRC5D. The therapy leverages Oricell's proprietary platforms including Ori®Ab...

 January 30, 2024 | News

Peijia Medical Completes Enrollment for TaurusTrio™ Aortic Regurgitation Trial

The multi-center trial utilized the TaurusTrioTM TAVR system to treat pure AR in 116 patients across 13 hospitals within China and is design...

 January 30, 2024 | News

Ractigen Therapeutics Partners with Utrecht Medical Center for saRNA Innovation in Neurodevelopmental Disorders

Professor Bobby Koeleman, Group Leader at the Department of Genetics within the Center for Molecular Medicine at Utrecht University, will le...

 January 30, 2024 | News

Travere Therapeutics Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics,announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin ...

 January 29, 2024 | News

Bristol Myers Squibb's Abecma CAR T Therapy Earns Favorable CHMP Opinion for Earlier Lines in Multiple Myeloma

Recommendation for approval based on Phase 3 KarMMa-3 study in which Abecma demonstrated superiority over standard regimens, significantly improv...

 January 26, 2024 | News

Merck's Strategic Agreement with Heavy Water Board Boosts Local Manufacturing for Deuterated Compounds in India

  In a recent interview with BioPharma APAC, Jean Charles Wirth, Executive Vice President of Science & Laboratory Solutions at Merck, sheds light...

 January 26, 2024 | Interview

Ceva Santé Animale Acquires Scout Bio for Innovative Pet Therapeutics

The move represents a significant leap in innovation for Ceva, unlocking access to key advancements including a pipeline of monoclonal antibodies and ...

 January 26, 2024 | News

AbbVie Invests $223M to Expand Biologics Manufacturing in Singapore

US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 emp...

 January 26, 2024 | News

Onward Therapeutics Initiates Phase 1 Trial for Bispecific Antibody OT-A201 Targeting Dual Immune Checkpoints

The study aims to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary anti-tumoral activity of OT-A201. The study is a Eur...

 January 25, 2024 | News

Merck and Mycenax Biotech Forge Partnership for Bioprocessing Innovation

Merck announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company&rsq...

 January 24, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close